Integrating New Approach Methodologies to De-risk CNS Drug Discovery
…seizure risk, abuse potential, and neurotoxicity, alongside emerging regulatory perspectives on New Approach Methodologies. The talk explains how combining these data can improve candidate selection and confidence in the safety of both CNS-targeted and other therap
Wed, Oct 21, 2026 · 15:00 UTC